Skip to content

Clinical trials

Completed Adenocarcinoma of Lung trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma of Lung Status: Completed Clear all

183 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20006
20018
20027
20034
200411
200511
20068
200710
20089
20095
20104
20118
20128
20136
20146
201510
20164
20174
20185
20196
202010
20214
20222
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed183

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alliance for Clinical Trials in Oncology22
National Cancer Institute (NCI)15
SWOG Cancer Research Network9
Novartis Pharmaceuticals8
Radiation Therapy Oncology Group8
Wake Forest University Health Sciences7
Memorial Sloan Kettering Cancer Center6
ECOG-ACRIN Cancer Research Group5
Swiss Cancer Institute5
Fudan University4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma of Lung183
Carcinoma, Non-Small-Cell Lung137
Lung Neoplasms120
Adenocarcinoma, Bronchiolo-Alveolar59
Neoplasms9
Neoplasm Metastasis6
Colonic Neoplasms5
Breast Neoplasms4
Carcinoma, Ovarian Epithelial4
Ovarian Neoplasms4

Trials

Showing 1 to 25 of 183. Each trial links to its page on Pharma Observatory.

83 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.